Filter
9518
Filtered Results: 9518
Text search:
treatment
data
Featured
Recommendations
779
New Publications
2436
Language
Document type
No document type
5457
Studies & Reports
1634
Guidelines
1103
Manuals
442
Strategic & Response Plan
325
Fact sheets
216
Training Material
133
Situation Updates
110
Infographics
37
Resource Platforms
30
Brochures
20
Online Courses
7
Dashboards/Maps
4
Countries / Regions
India
400
Global
378
Kenya
271
South Africa
213
Western and Central Europe
211
Sierra Leone
206
Ethiopia
197
Liberia
188
Nigeria
178
Uganda
174
Nepal
166
Malawi
147
Latin America and the Carribbean
144
Tanzania
140
Myanmar / Burma
140
Bangladesh
136
Zambia
135
Africa
133
Rwanda
115
Syria
110
Ghana
109
Ukraine
105
Indonesia
89
Eastern Europe
81
Namibia
79
Congo, Democratic Republic of
78
Zimbabwe
77
Philippines
75
Mozambique
70
South Sudan
69
Lesotho
67
Brazil
61
Russia
61
Guinea
55
Cambodia
55
South–East Asia Region
53
Haiti
50
Asia
50
Senegal
46
East and Southern Africa
45
Botswana
45
Burkina Faso
44
Yemen
44
West and Central Africa
42
Germany
41
Middle East and North Africa
38
Venezuela
32
Eastern Europe and Central Asia
32
Eswatini/ Swaziland
32
Cameroon
29
Colombia
27
Pakistan
26
Benin
24
Afghanistan
24
Sudan
24
Madagascar
24
Jordan
20
Central African Republic
19
Lebanon
18
Somalia
18
Tajikistan
17
Thailand
16
China
16
Mali
16
Albania
15
USA
15
Argentina
14
Vietnam
14
Moldova
14
Iraq
13
Paraguay
12
North America
11
Papua New Guinea
11
Georgia
11
Angola
11
Chile
10
Peru
10
Bolivia
10
Sri Lanka
10
Western Pacific Region
9
Turkey
8
Iran
8
Armenia
8
Palestine
8
Ecuador
8
North Macedonia
7
Laos
7
Kyrgyzstan
7
Niger
7
Burundi
7
Guinea-Bissau
7
United Kingdom
7
Spain
7
Libya
7
Gambia
6
Southern Africa
6
Côte d’Ivoire / Ivory Coast
6
Egypt
6
Romania
6
Greece
6
Poland
6
Chad
6
Timor Leste/ East Timor
5
Mexico
5
Kazakhstan
5
Malaysia
5
Hungary
5
Jamaica
5
Bhutan
5
Serbia
4
Togo
4
Estonia
4
Uzbekistan
4
Morocco
4
Portugal
4
Belarus
4
Switzerland
3
El Salvador
3
Canada
3
Singapore
3
Mongolia
3
Saudi Arabia
3
Turkmenistan
3
Japan
3
Mauritius
3
Tunisia
3
Azerbaijan
3
Djibouti
3
Qatar
2
Bulgaria
2
Mauritania
2
Italy
2
Croatia
2
Lithuania
2
Gabon
2
Slovakia
2
Honduras
2
North Korea
1
Australia
1
Fiji
1
Austria
1
Vanuatu
1
Ireland
1
Denmark
1
Belgium
1
France
1
Maldives
1
Norway
1
Algeria
1
French Guyana
1
Israel
1
Bosnia and Herzegovina
1
Latvia
1
Nicaragua
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
3588
Clinical Guidelines
724
Public Health
497
Key Resources
429
Women & Child Health
423
Capacity Building
163
Pharmacy & Technologies
88
Annual Report MEDBOX
3
Toolboxes
HIV
877
Mental Health
808
COVID-19
742
TB
623
NTDs
358
AMR
299
Ebola & Marburg
283
Disability
270
Rapid Response
255
Conflict
243
Caregiver
241
Planetary Health
220
NCDs
204
Refugee
172
Pharmacy
171
Global Health Education
120
Health Financing Toolbox
108
Natural Hazards
94
Cholera
59
Zika
52
Specific Hazards
49
Polio
34
Social Ethics
20
Malaria
19
Typhoon
5
South Sudan
2
Asthma prevalence is increasing worldwide and surveys indicate that the majority of patients in developed and developing countries do not receive optimal care and are therefore not well controlled. The aim of these guidelines is to promote a better standard of treatment based on advances in the unde...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Reports of antimicrobial-resistant (AMR) microorganisms are increasing globally, threatening to render existing treatments ineffective against many infectious diseases. In Africa, AMR has already been documented to be a problem for human immunodeficiency virus (HIV) and the pathogens that cause mala...
Global Biodiversity Outlook (GBO) is the flagship publication of the Convention on Biological Diversity (CBD). It is a periodic report that summarizes the latest data on the status and trends of biodiversity and draws conclusions relevant to the further implementation of the Convention.
GBO-5 provi...
The World Health Organization (WHO) recognizes the challenges countries face for maintaining their COVID-19 response while addressing competing public health challenges, conflicts, climate change and economic crises.
It remains critical for national programmes to continue to offer testing for COVI...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
The document provides guidelines for the prevention and control of cholera outbreaks. It focuses on key strategies such as improving access to safe drinking water, ensuring proper sanitation, and promoting hygiene practices to prevent the spread of the disease. The guidelines also emphasize the impo...
The core of the strategy is the goal for all patients to have better overall care, so that the numbers of deaths and cases of disability are reduced by 50% before 2030. For this to be achieved, four strategic aims will be pursued.
Empower and engage communities,
Ensure safe, effective trea...
Cancer
recommended
This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alte...
WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050.
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i...
The executive summary of the WHO Global oral health status report presents a snapshot of the most recent data on major oral diseases, risk factors, health system challenges and opportunities for reform. The report’s clear conclusion is that the status of global oral health is alarming and requires...
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
Policy Brief, Updated in March 2017
Key messages
• The criminalisation of male-to-male sex heightens HIV and other sexually transmissible infection (STI) risks and vulnerabilities, and hinders access to HIV and STI services including HCT.
• Men who have sex with men (MSM) and tran...
Key messages
• The criminalisation of male-to-male sex heightens HIV and other sexually transmissible infection (STI) risks and vulnerabilities, and hinders access to HIV and STI services including HCT.
• Men who have sex with men (MSM) and tran...
The aims of these guidelines are to provide guidance to health-care providers (i.e. the end-users of these guidelines: physicians, nurses, pharmacists and caregivers) on the adequate relief of pain associated with cancer. They also assist policy-makers, programme managers and public health personnel...
Monitoring of implementation of collaborative TB/HIV activities and evaluation of impact is critically important. This requires efficient monitoring and evaluation system so as to establish accountability mechanisms between programmes, the population they serve, and donors. The Guide to monitoring a...
Mycetoma is a chronic, progressively destructive infectious disease of the subcutaneous tissues, affecting skin, muscle and bone. Mycetoma occurs in tropical and subtropical environments characterized by short rainy seasons and prolonged dry seasons that favour the growth of thorny bushes. Global bu...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
In 2019, an estimated 10 million individuals fell ill with tuberculosis (TB) and 3 million of them were not reported to have beendiagnosed and notified. The gap is proportionately even wider for drug-resistant TB. Of the estimated 465 000 patients with rifampicin-resistant and multi-drug resistant T...
